Edition:
United Kingdom

PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

2.48USD
23 Feb 2018
Change (% chg)

$-0.02 (-0.80%)
Prev Close
$2.50
Open
$2.51
Day's High
$2.55
Day's Low
$2.46
Volume
194,113
Avg. Vol
373,704
52-wk High
$3.55
52-wk Low
$1.96

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 62.75 0.136
Jun '17 143.84 0.386
Mar '17 45.44 0.044
FY 2016 Dec '16 66.49 -0.063
Sep '16 53.64 0.085
Jun '16 21.05 0.025
Mar '16 103.12 0.341
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 42.10 42.10 42.10 --
Quarter Ending Jun-18 1 43.60 43.60 43.60 --
Year Ending Dec-18 2 137.15 170.10 104.20 176.59
Earnings (per share)
Quarter Ending Mar-18 1 0.01 0.01 0.01 --
Quarter Ending Jun-18 1 0.03 0.03 0.03 --
Year Ending Dec-18 2 0.01 0.10 -0.07 0.16
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 7.56 83.93 32.90
P/E High - Last 5 Yrs. 5.47 292.71 45.97
P/E Low - Last 5 Yrs. 1.74 91.44 24.37
Beta 0.56 0.90 0.89
Price to Sales (TTM) 1.70 110.72 5.77
Price to Book (MRQ) 0.64 13.56 5.41
Price to Tangible Book (MRQ) 2.13 14.02 6.98
Price to Cash Flow (TTM) 5.52 71.33 23.42
% Owned Institutions 85.95 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg 8.67 0.26 1.52
Dividend 5 Year Growth Rate -30.12 1.66 5.21
Payout Ratio(TTM) 0.00 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 583.40 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -27.51 78.63 5.59
Sales - 5 Yr. Growth Rate -7.57 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 1,428.07 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago -67.71 -- --
EPS - 5 Yr. Growth Rate -6.64 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.90 1.80 2.18
Current Ratio (MRQ) 1.94 5.30 2.97
LT Debt to Equity (MRQ) 13.93 22.82 12.22
Total Debt to Equity (MRQ) 29.05 24.47 16.52
Interest Coverage (TTM) 19.59 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 79.07 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) 76.24 -- --
EBITD - 5 Yr. Avg 92.67 -572.68 10.86
Operating Margin (TTM) 51.77 -717.10 4.64
Operating Margin - 5 Yr. Avg. 89.03 -594.00 6.26
Pre-Tax Margin (TTM) 45.82 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. 82.99 -597.35 6.60
Net Profit Margin (TTM) 23.03 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. 53.03 -600.21 2.91
Effective Tax Rate (TTM) 49.74 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. 36.09 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 28,127,730 22,602,130 855,673,508
Net Income/Employee (TTM) 6,477,909 2,968,748 100,656,226
Receivable Turnover (TTM) 3.41 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.26 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 6.06 -1.05 10.98
Return on Assets - 5 Yr. Avg. 33.75 -0.57 12.37
Return on Investment (TTM) 6.94 1.66 14.43
Return on Investment - 5 Yr. Avg. 43.22 2.23 16.18
Return on Equity (TTM) 9.15 2.58 16.13
Return on Equity - 5 Yr. Avg. 81.00 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -58.62 -18.80 -7.57
EPS (TTM) % -80.96 -38.44 -6.64
Dividend % -83.33 -44.97 -30.12
Note: Units in Millions of US Dollars

Performance for PDL BioPharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.89 4.17 99 53
13 Week 43.70 36.70 99 62
26 Week 66.02 53.40 99 77
52 Week 5.23 -10.81 99 50
YTD 61.32 41.67 99 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 92.87%
# of Holders: 259
Total Shares Held: 143,337,456
3 Mo. Net Change: 2,976,145
# New Positions: 30
# Closed Positions: 33
# Increased Positions: 102
# Reduced Positions: 109
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.